Abstract: The present disclosure relates to a component with a movable display device and a cockpit component. The component includes a base, wherein the base provides a storage space, and the storage space has an opening; a cover assembly, being capable of opening or closing the opening, wherein the cover assembly includes a first cover and a second cover arranged adjacent to each other in a length direction, and the first cover being able to correspondingly cover a first area of the opening, and the second cover being able to correspondingly cover a second area of the opening; a movable display device; wherein, the component has a first state and a second state; in the first state, the first cover covers the first area of the opening, the second cover covers the second area of the opening, and the movable display device is located inside the storage space and is non-visible.

Abstract: Methods for preparing bioprosthetic tissue are provided. In some instances, bioprosthetic tissue is treated to remove antigenic biomolecules. In some instances, prepared bioprosthetic tissues are incorporated into a medical device.

Abstract: Methods for reducing cardiac pressure involve advancing a surgical instrument into a left atrium of a heart and into a pulmonary vein fluidly coupled to the left atrium. A first opening is formed in a wall portion of the pulmonary vein and a second opening is formed in a wall portion of a pulmonary artery. A shunt implant is deployed through the first and second openings such that the shunt implant extends between the pulmonary vein and the pulmonary artery and defines a shunt flow path therebetween. Blood is shunted from the pulmonary vein into the pulmonary artery through the shunt flow path. In some implementations, the pulmonary vein and the pulmonary artery are drawn toward one another prior to deployment of the shunt implant, and the shunt implant clamps tissue of the pulmonary vein and tissue of the pulmonary artery together to establish a fluid-tight shunt pathway.

Abstract: Methods for preparing bioprosthetic tissue are provided. In some instances, bioprosthetic tissue is treated to remove antigenic biomolecules. In some instances, prepared bioprosthetic tissues are incorporated into a medical device.

Abstract: Artificial heart valves, their manufacture, and methods of use are described. Generally, artificial heart valves can be deployed to replace or supplement defective heart valves in a patient. These artificial heart valves can comprise a frame with an inner skirt and leaflets. These inner skirt and leaflets can be generated from regenerative tissue to allow integration of the tissue with the body of a patient, while the frame can be generated from bioabsorbable material to allow dissolution of the frame over time. This combination of materials may allow for the artificial valve to grow with a patient and avoid costly and potentially dangerous replacement for patients receiving artificial valves.

Abstract: A method of shunting blood involves accessing a left atrium of a heart with a surgical instrument, advancing the surgical instrument into a pulmonary vein fluidly coupled to the left atrium, forming an opening in a wall portion of the pulmonary vein, and shunting blood from the pulmonary vein into a right-side structure of the heart through the opening in the wall portion of the pulmonary vein.

Abstract: A method of applying fibrous material to a medical device component involves coupling a prosthetic heart valve docking frame to a holder device coupled to a rotating mandrel, the prosthetic heart valve docking frame comprising a proximal cylindrical anchor frame and a plurality of legs extending from a distal end of the anchor frame, straightening the plurality of legs such that they point axially with respect to an axis of the anchor frame, ejecting a liquid polymeric solution from a reservoir to form one or more strands of fibrous material in a deposition plane, and rotating the holder device at least partially within the deposition plane to apply at least a first portion of the one or more strands of fibrous material to outer surfaces of the plurality of legs, thereby forming a fibrous covering on the outer surfaces of the plurality of legs.

Abstract: A cardiac device configured to be positioned in a heart includes a body configured to be positioned in a wall between a right pulmonary vein and a right atrium or a superior vena cava and a sensor attached to the cardiac device. The sensor includes a sensor housing, a transducer, and control circuitry in the sensor housing in electrical communication with the transducer that is configured to sense a signal from a fluid in the right pulmonary vein, the right atrium, or the superior vena cava or a signal from the heart.

Abstract: A method of applying fibrous material to a medical device component involves coupling a medical device component a holder device, rotating a reservoir device containing a liquid polymeric solution to expel at least a portion of the liquid polymeric solution from an orifice of the reservoir device, the expelled at least a portion of the liquid polymeric solution forming one or more strands of fibrous material in a deposition plane, and rotating the holder device at least partially within the deposition plane to apply at least a first portion of the one or more strands of fibrous material to one or more surfaces of the medical device component, thereby forming a fibrous covering on the one or more surfaces of the medical device component.

Abstract: Multiple anchors are transluminally slid distally over and along a first portion of a tether to a heart of a subject. The anchors are anchored to tissue of the heart, with the first portion of the tether extending transluminally to the heart. Within the heart, a bight of the tether is secured to the tissue by the anchors. A second portion of the tether extends from the bight to a second end of the tether. The first portion of the tether is subsequently slidably coupled to the second end of the tether such that the tether forms a closed loop. The tissue is subsequently reshaped by the loop being reduced in size by the first portion being slid through the slidable coupling. Other embodiments are also described.

Abstract: Disclosed is an efficient nitrogen and phosphorus removal process system for mariculture tail water treatment. The process system comprises a physical filtering device, an efficient biological treatment unit, a flocculation sedimentation tank, a sand filtering tank, a clean water tank and a sludge tank, wherein the physical filtering device, the efficient biological treatment unit, the flocculation sedimentation tank, the sand filtering tank and the clean water tank are sequentially connected; the physical filtering device, the efficient biological treatment unit, the flocculation sedimentation tank and the sand filtering tank are all connected with the sludge tank through pipelines, and the physical filtering device and the sand filtering tank are both connected with the clean water tank through pipelines.

Abstract: Devices and methods for reinforcing a tissue-based heart valve are provided. A reinforced tissue valve can provide structure and rigidity to withstand stresses that occur within the vasculature. In some instances, thickened tissue provides structure or rigidity. In some instances, a biocompatible filler is utilized within folded, rolled, or layered tissue. In some instances, a mesh is included with a reinforced tissue valve for further strength. In some instances, a mesh frame is utilized along the sidewall of a tissue-based heart valve. In some instances, a leaflet assembly is provided within a conduit having thickened tissue at the leaflet commissures.

Abstract: Artificial heart valves, their manufacture, and methods of use are described. Generally, artificial heart valves can be deployed to replace or supplement defective heart valves in a patient. These artificial heart valves can comprise a frame with an inner skirt and leaflets. These inner skirt and leaflets can be generated from regenerative tissue to allow integration of the tissue with the body of a patient, while the frame can be generated from bioabsorbable material to allow dissolution of the frame over time. This combination of materials may allow for the artificial valve to grow with a patient and avoid costly and potentially dangerous replacement for patients receiving artificial valves.

Abstract: Artificial heart valves, their manufacture, and methods of use are described. Generally, artificial heart valves can be deployed to replace or supplement defective heart valves in a patient. These artificial heart valves can comprise a frame with an inner skirt and leaflets. These inner skirt and leaflets can be generated from regenerative tissue to allow integration of the tissue with the body of a patient, while the frame can be generated from bioabsorbable material to allow dissolution of the frame over time. This combination of materials may allow for the artificial valve to grow with a patient and avoid costly and potentially dangerous replacement for patients receiving artificial valves.

Abstract: An annuloplasty ring prosthesis comprising a frame having an outer surface; and a cover surrounding the frame. The cover comprises a bioprosthetic tissue that can be regenerative or fixed and non-regenerative. The frame can be bioabsorbable or non-degradable. A ring prosthesis and a method of manufacturing a ring prosthesis is also provided. The ring prosthesis comprising an elongated rod member formed into a substantially ring shape, the elongated rod member being formed substantially from a flat bioprosthetic tissue.

Abstract: Methods for preparing bioprosthetic tissue are provided. In some instances, bioprosthetic tissue is treated to remove antigenic biomolecules. In some instances, prepared bioprosthetic tissues are incorporated into a medical device.

Abstract: A method of shunting blood involves accessing a left atrium of a heart with a surgical instrument, advancing the surgical instrument into a pulmonary vein fluidly coupled to the left atrium, forming an opening in a wall portion of the pulmonary vein, and shunting blood from the pulmonary vein into a right-side structure of the heart through the opening in the wall portion of the pulmonary vein.

Abstract: A method of applying fibrous material to a medical device component involves coupling a medical device component a holder device, rotating a reservoir device containing a liquid polymeric solution to expel at least a portion of the liquid polymeric solution from an orifice of the reservoir device, the expelled at least a portion of the liquid polymeric solution forming one or more strands of fibrous material in a deposition plane, and rotating the holder device at least partially within the deposition plane to apply at least a first portion of the one or more strands of fibrous material to one or more surfaces of the medical device component, thereby forming a fibrous covering on the one or more surfaces of the medical device component.

Abstract: Devices and methods for reinforcing a regenerative heart valve are provided. A reinforcing element can provide structure and rigidity to withstand stresses that occur within the aortic root. In some instances, a support ring is attached to a regenerative heart valve. In some instances, a tubular wall is provided surrounding a regenerative heart valve.

Abstract: A method of delivering magnetic particles to a target site, including inserting a magnet catheter into a blood vessel; advancing the magnet catheter to a position downstream from the target site; and releasing magnetic particles into the blood vessel upstream of the target site; in which a first portion of the magnetic particles embolize in the blood vessel is disclosed. A system is also disclosed.